Rock Springs Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 263,062 shares of MDGL stock, worth $77.2 Million. This represents 1.9% of its overall portfolio holdings.
Number of Shares
263,062
Previous 245,499
7.15%
Holding current value
$77.2 Million
Previous $68.8 Million
18.83%
% of portfolio
1.9%
Previous 2.13%
Shares
25 transactions
Others Institutions Holding MDGL
# of Institutions
295Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$728 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$600 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$596 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$585 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$580 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.02B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...